In partnership with
Letter from the Editor
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Patients with polyvascular disease significantly undertreated with lipid lowering therapies
DECLARE TIMI-58 trial shows benefits of dapagliflozin in high-risk subgroups
Superior outcomes of DES compared with BMS in very elderly population
Diagnosing cardiac sarcoidosis with endomyocardial biopsies
Substantial impact of temporary interruptions of warfarin versus DOAC
Less bleeding and fewer hospitalisations with antithrombotic regimen with apixaban without aspirin
Smartwatch can detect atrial fibrillation with high degree of accuracy
Higher incidence arrhythmia post-percutaneous closure of secundum ASD in patients >60 years
Unplanned hospital readmission is common after congenital cardiac surgery
Frequent use of beta-blocker after HFpEF hospitalisations in elderly patients without compelling indications
BNP still a reliable prognostic marker before and during sacubitril/valsartan treatment
High 5-year survival rates for older HF patients without initial severe comorbidity
Apixaban is safe and effective in real-world setting for treatment of venous thromboembolism
Treatment patterns PAH have changed recently
TAVR superior and non-inferior to SAVR in low-risk patients
Immediate angiography not better than delayed angiography in non-STEMI cardiac arrest patients
Ticagrelor monotherapy safe after dual antiplatelet therapy
P2Y12 inhibitor monotherapy is a novel antiplatelet strategy after short duration DAPT
Similar MACE rates but higher all-cause mortality in PAD patients with diabetes
Lower rates stroke/SE with DOACs in frail non-valvular AF patients
Similar rates of stroke/SE associated with DOAC vs warfarin use in obese non-valvular AF patients: Results from an observational registry
Convincing evidence of the role of icosapent in reducing subsequent CV events
Clopidogrel monotherapy after 1-month DAPT may be beneficial in stent patients
Early discharge and home treatment feasible for low-risk pulmonary embolism patients
Top image: © Lifemoment
The content and interpretation of these conference highlights are the views and comments of the speakers/ authors.
BACK TO TOP